中国进出口商品交易会，又称广交会，创办于1957年春，每年春秋两季在广州举办。广交会由商务部和广东省人民政府联合主办，中国对外贸易中心承办，是中国目前历史最长、规模最大、商品最全、采购商最多且来源最广、成交效果最好、信誉最佳的综合性国际贸易盛会，被誉为“中国第一展”、中国外贸的“晴雨表”“风向标”。
The China Import and Export Fair, also known as the Canton Fair, was first held in the spring of 1957 and takes place every spring and autumn in Guangzhou. Co-sponsored by the Ministry of Commerce and the People's Government of Guangdong Province, and organized by the China Foreign Trade Centre, the Canton Fair is China’s most time-honored, largest-scale, most comprehensive in product offerings, broadest in buyer base (covering the most sources), best in transaction outcomes, and most reputable comprehensive international trade event. It is proudly hailed as “China’s No.1 Fair” and the “barometer and bellwether” of China’s foreign trade.
第139届广交会已火热开启，久心医疗将携多款创新产品在大会第三期精彩亮相，诚邀海内外客户和合作伙伴莅临久心展台，共同探讨院前急救体系建设与创新发展。
The 139th Canton Fair is now in full swing, and Jousing will make a splendid appearance in Phase III with a range of innovative products. We sincerely invite domestic and international customers and partners to visit the Jousing booth to explore the development and innovative construction of pre-hospital emergency systems together.
Date/展会时间：2026/5/1-5/5
Address/展会地点：
Guangzhou-China Import and Export Complex
广州·中国进出口商品交易会展馆
Booth/展位号：B区 9.2D48
久心医疗是中国首家获AED注册证的民族企业，提供AED产品及院前急救解决方案。公司参与编写国家药监局《体外除颤产品注册技术审查指导原则》，荣获国家高新技术企业、国家级专精特新“小巨人”企业称号。2022年，久心医疗为北京冬奥会提供独家AED保障。
Jousing is China's first domestic enterprise to obtain an AED registration certificate, providing AED products and pre-hospital emergency solutions. The company participated in drafting the NMPA's "Technical Guiding Principles for Defibrillator Product Registration," and has been recognized as a National High-Tech Enterprise and a National-Level "Specialized, Refined, Unique, and New" (Little Giant) Enterprise. In 2022, Jousing provided exclusive AED support for the Beijing Winter Olympics.
久心医疗国内AED装机量约10万台，并已出口欧洲、澳洲、东南亚、南美等30余个国家及地区。久心AED产品动物实验首次除颤成功率超98%，行业领先。目前已累计成功救治220余名患者。
Jousing has installed approximately 100,000 AED units in China and exported to over 30 countries and regions, including Europe, Australia, Southeast Asia, and South America. The first-shock success rate of Jousing AED products in animal trials exceeds 98%, leading the industry. To date, they have successfully resuscitated more than 220 patients.
